Legend Biotech EU

Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI®, a one-time treatment for relapsed or refractory multiple myeloma, developed and marketed in collaboration with Johnson & Johnson. Headquartered in Somerset, New Jersey, USA, Legend Biotech has a significant presence in Europe, including a European headquarters in Dublin, Ireland. ([linkedin.com](https://www.linkedin.com/company/legendbiotechco.?utm_source=openai))